194 related articles for article (PubMed ID: 36306983)
1. Dual-crosslinked bioprosthetic heart valves prepared by glutaraldehyde crosslinked pericardium and poly-2-hydroxyethyl methacrylate exhibited improved antithrombogenicity and anticalcification properties.
Huang X; Zheng C; Ding K; Zhang S; Lei Y; Wei Q; Yang L; Wang Y
Acta Biomater; 2022 Dec; 154():244-258. PubMed ID: 36306983
[TBL] [Abstract][Full Text] [Related]
2. A universal strategy for the construction of polymer brush hybrid non-glutaraldehyde heart valves with robust anti-biological contamination performance and improved endothelialization potential.
Yu T; Zheng C; Chen X; Pu H; Li G; Jiang Q; Wang Y; Guo Y
Acta Biomater; 2023 Apr; 160():87-97. PubMed ID: 36812953
[TBL] [Abstract][Full Text] [Related]
3. A versatile modification strategy for functional non-glutaraldehyde cross-linked bioprosthetic heart valves with enhanced anticoagulant, anticalcification and endothelialization properties.
Yu T; Pu H; Chen X; Kong Q; Chen C; Li G; Jiang Q; Wang Y
Acta Biomater; 2023 Apr; 160():45-58. PubMed ID: 36764592
[TBL] [Abstract][Full Text] [Related]
4. A PEGylation method of fabricating bioprosthetic heart valves based on glutaraldehyde and 2-amino-4-pentenoic acid co-crosslinking with improved antithrombogenicity and cytocompatibility.
Ding K; Zheng C; Huang X; Zhang S; Li M; Lei Y; Wang Y
Acta Biomater; 2022 May; 144():279-291. PubMed ID: 35365404
[TBL] [Abstract][Full Text] [Related]
5. A synergistic strategy of dual-crosslinking and loading intelligent nanogels for enhancing anti-coagulation, pro-endothelialization and anti-calcification properties in bioprosthetic heart valves.
Hu M; Shi S; Peng X; Pu X; Yu X
Acta Biomater; 2023 Nov; 171():466-481. PubMed ID: 37793601
[TBL] [Abstract][Full Text] [Related]
6. Arginine-grafted porcine pericardium by copolymerization to improve the cytocompatibility, hemocompatibility and anti-calcification properties of bioprosthetic heart valve materials.
Liang X; Zheng C; Ding K; Huang X; Zhang S; Lei Y; Yu K; Wang Y
J Mater Chem B; 2022 Jul; 10(29):5571-5581. PubMed ID: 35791926
[TBL] [Abstract][Full Text] [Related]
7. Radical polymerization-crosslinking method for improving extracellular matrix stability in bioprosthetic heart valves with reduced potential for calcification and inflammatory response.
Guo G; Jin L; Jin W; Chen L; Lei Y; Wang Y
Acta Biomater; 2018 Dec; 82():44-55. PubMed ID: 30326277
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic Acid-Grafted Bioprosthetic Heart Valves Achieved by Copolymerization Exhibited Improved Anticalcification and Antithrombogenicity.
Huang X; Zheng C; Ding K; Li M; Zhang S; Wu B; Wei Q; Lei Y; Wang Y
ACS Biomater Sci Eng; 2022 Aug; 8(8):3399-3410. PubMed ID: 35839344
[TBL] [Abstract][Full Text] [Related]
9. Dialdehyde pectin-crosslinked and hirudin-loaded decellularized porcine pericardium with improved matrix stability, enhanced anti-calcification and anticoagulant for bioprosthetic heart valves.
Hu M; Peng X; Zhao Y; Yu X; Cheng C; Yu X
Biomater Sci; 2021 Nov; 9(22):7617-7635. PubMed ID: 34671797
[TBL] [Abstract][Full Text] [Related]
10. A functionalized biological heart valve by double bond crosslinking with enhanced biocompatibility and antithrombogenicity.
Zheng C; Kuang D; Ding K; Huang X; Fan H; Yang L; Wang Y; Zhang X
J Mater Chem B; 2022 Dec; 10(48):10001-10017. PubMed ID: 36472327
[TBL] [Abstract][Full Text] [Related]
11. A versatile drug-controlled release polymer brush hybrid non-glutaraldehyde bioprosthetic heart valves with enhanced anti-inflammatory, anticoagulant and anti-calcification properties, and superior mechanical performance.
Yu T; Li G; Chen X; Kuang D; Jiang Q; Guo Y; Wang Y
Biomaterials; 2023 May; 296():122070. PubMed ID: 36868031
[TBL] [Abstract][Full Text] [Related]
12. Poly(2-methoxyethyl acrylate) coated bioprosthetic heart valves by copolymerization with enhanced anticoagulant, anti-inflammatory, and anti-calcification properties.
Liang X; Lei Y; Ding K; Huang X; Zheng C; Wang Y
J Mater Chem B; 2022 Dec; 10(48):10054-10064. PubMed ID: 36448545
[TBL] [Abstract][Full Text] [Related]
13. Zwitterionic hydrogel-coated heart valves with improved endothelialization and anti-calcification properties.
Luo Y; Huang S; Ma L
Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112329. PubMed ID: 34474880
[TBL] [Abstract][Full Text] [Related]
14. A bioprosthetic heart valve cross-linked by a non-glutaraldehyde reagent with improved biocompatibility, endothelialization, anti-coagulation and anti-calcification properties.
Yu T; Yang W; Zhuang W; Tian Y; Kong Q; Chen X; Li G; Wang Y
J Mater Chem B; 2021 May; 9(19):4031-4038. PubMed ID: 33908590
[TBL] [Abstract][Full Text] [Related]
15. Double-Network Hydrogel Armored Decellularized Porcine Pericardium as Durable Bioprosthetic Heart Valves.
Cheng S; Liu X; Qian Y; Maitusong M; Yu K; Cao N; Fang J; Liu F; Chen J; Xu D; Zhu G; Ren T; Wang J
Adv Healthc Mater; 2022 Apr; 11(8):e2102059. PubMed ID: 34969157
[TBL] [Abstract][Full Text] [Related]
16. Inorganic-polymerization crosslinked tissue-siloxane hybrid as potential biomaterial for bioprosthetic heart valves.
Yang F; He H; Xu L; Jin L; Guo G; Wang Y
J Biomed Mater Res A; 2021 May; 109(5):754-765. PubMed ID: 32681740
[TBL] [Abstract][Full Text] [Related]
17. Crosslinking porcine aortic valve by radical polymerization for the preparation of BHVs with improved cytocompatibility, mild immune response, and reduced calcification.
Xu L; Yang F; Ge Y; Guo G; Wang Y
J Biomater Appl; 2021 Apr; 35(9):1218-1232. PubMed ID: 33478311
[TBL] [Abstract][Full Text] [Related]
18. A chlorogenic acid functional strategy of anti-inflammation, anti-coagulation and promoted endothelial proliferation for bioprosthetic artificial heart valves.
Chen X; Yu T; Kong Q; Xu H; Zhao Z; Li G; Fan H; Wang Y
J Mater Chem B; 2023 Mar; 11(12):2663-2673. PubMed ID: 36883900
[TBL] [Abstract][Full Text] [Related]
19. Visible light-induced cross-linking of porcine pericardium for the improvement of endothelialization, anti-tearing, and anticalcification properties.
Yang F; Xu L; Guo G; Wang Y
J Biomed Mater Res A; 2022 Jan; 110(1):31-42. PubMed ID: 34245103
[TBL] [Abstract][Full Text] [Related]
20. Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1/β4GalNT2/CMAH.
Zhang R; Wang Y; Chen L; Wang R; Li C; Li X; Fang B; Ren X; Ruan M; Liu J; Xiong Q; Zhang L; Jin Y; Zhang M; Liu X; Li L; Chen Q; Pan D; Li R; Cooper DKC; Yang H; Dai Y
Acta Biomater; 2018 May; 72():196-205. PubMed ID: 29631050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
